DEF: Annovis Bio, Inc. Announces Details for 2025 Annual Stockholders Meeting

Annovis Bio, Inc. has scheduled its 2025 Annual Meeting of Stockholders for June 17, 2025, to be held virtually.

Summary

• Annovis Bio, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 17, 2025, at 10:00 a.m. Eastern Time.
• Stockholders of record as of April 28, 2025, are entitled to vote.
• The meeting will include voting on the election of five directors and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The Board of Directors recommends voting FOR the election of all director nominees and FOR the ratification of Ernst & Young LLP.
• Proxy materials are primarily available over the Internet, with a Notice of Internet Availability mailed to stockholders on or about May 2, 2025.
• Stockholders can request paper copies of the proxy materials.
• The company has engaged Alliance Advisors to assist with proxy solicitation efforts, with an estimated fee of $24,510 for their services.
• Directors and executive officers beneficially own approximately 20.8% of the outstanding common stock and are expected to vote in favor of the proposals.

Sentiment

Score: 7

Explanation: The document is primarily informational and procedural, with a neutral to slightly positive tone due to the Board's recommendations and emphasis on stockholder participation.

Positives

• The company is utilizing internet distribution of proxy materials to expedite receipt by stockholders, lower costs, and conserve natural resources.
• Stockholders have multiple options for voting, including online, telephone, and mail.
• The virtual format of the Annual Meeting facilitates stockholder attendance and participation from any location at no cost.
• The Board has determined that Michael Hoffman, Claudine Bruck and Reid McCarthy are independent within the meaning of Section 303A.02 of the NYSE Listed Company Manual and Rule 10A-3 under the Securities Exchange Act of 1934, as amended.

Risks

• Climate related changes can increase the frequency and severity of significant weather events and natural disasters.
• Increased attention on ESG matters, including from our customers, shareholders and other stakeholders, may lead to us expending more resources addressing these issues.
• Legislative and regulatory efforts to combat climate change and address ESG issues may prove costly and burdensome for us to comply with and will likely continue to impact us, our customers and our suppliers.

Future Outlook

The document outlines procedures for stockholders to present proposals and director nominations for the 2026 Annual Meeting.

Management Comments

• Maria Maccecchini, President and Chief Executive Officer, encourages stockholders to vote their shares.
• The Board of Directors unanimously recommends that you vote FOR the election of all of the director nominees and FOR the proposal to ratify Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

Industry Context

This is a standard proxy statement for a publicly traded company, outlining the agenda and procedures for the annual meeting, as well as providing information on corporate governance and executive compensation.

Comparison to Industry Standards

• The structure and content of this proxy statement are consistent with industry standards for publicly traded companies in the United States.
• The company's approach to corporate governance, including the establishment of Audit, Compensation, and Nominating Committees, aligns with best practices.
• The disclosure of executive and director compensation is in line with SEC requirements and industry norms.
• The process for stockholders to submit proposals and director nominations is consistent with Rule 14a-8 of the Exchange Act and the company's bylaws.

Stakeholder Impact

• Shareholders are directly impacted through their voting rights and participation in the Annual Meeting.
• Employees are indirectly impacted through the election of directors and the ratification of the accounting firm.
• The outcome of the proposals could affect the company's financial reporting and corporate governance practices.

Next Steps

• Stockholders should review the proxy materials and vote their shares before the Annual Meeting.
• Stockholders who wish to attend the virtual Annual Meeting must register by June 14, 2025.
• The company will file a Current Report on Form 8-K to report the voting results within four business days following the Annual Meeting.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Ernst & Young, Voting, Annovis Bio